207 related articles for article (PubMed ID: 12673111)
21. Cytotoxic chemotherapy for advanced colorectal cancer. Recent advances in management.
Kopetz S; Hoff PM
Oncology (Williston Park); 2005 Nov; 19(13 Suppl 6):11-7. PubMed ID: 16502665
[TBL] [Abstract][Full Text] [Related]
22. Recent and ongoing clinical trials for treating colorectal cancer.
Mulcahy MF; Benson AB
Expert Opin Investig Drugs; 2002 Jun; 11(6):871-80. PubMed ID: 12036430
[TBL] [Abstract][Full Text] [Related]
23. The role of oxaliplatin in the treatment of advanced metastatic colorectal cancer: prospects and future directions.
Schmoll HJ
Semin Oncol; 2002 Oct; 29(5 Suppl 15):34-9. PubMed ID: 12422306
[TBL] [Abstract][Full Text] [Related]
24. Current and emerging therapies for metastatic colorectal cancer: applying research findings to clinical practice.
Hecht JR
Am J Health Syst Pharm; 2008 Jun; 65(11 Suppl 4):S15-21; quiz S22-4. PubMed ID: 18499885
[TBL] [Abstract][Full Text] [Related]
25. Advances in the treatment of metastatic colorectal cancer.
Fishman AD; Wadler S
Clin Colorectal Cancer; 2001 May; 1(1):20-35. PubMed ID: 12445376
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy for metastatic colorectal cancer.
Rosales J; Leong LA
J Natl Compr Canc Netw; 2005 Jul; 3(4):525-9. PubMed ID: 16038643
[TBL] [Abstract][Full Text] [Related]
27. New systemic frontline treatment for metastatic colorectal carcinoma.
Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
[TBL] [Abstract][Full Text] [Related]
28. New developments in systemic chemotherapy in advanced colorectal cancer.
Cats A
Scand J Gastroenterol Suppl; 2003; (239):78-86. PubMed ID: 14743888
[TBL] [Abstract][Full Text] [Related]
29. A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/- targeted therapy.
Nielsen DL; Palshof JA; Larsen FO; Jensen BV; Pfeiffer P
Cancer Treat Rev; 2014 Jul; 40(6):701-15. PubMed ID: 24731471
[TBL] [Abstract][Full Text] [Related]
30. New chemotherapeutic strategies in colorectal cancer.
Moehler M; Teufel A; Galle PR
Recent Results Cancer Res; 2005; 165():250-9. PubMed ID: 15865041
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer: integrating oxaliplatin.
Louvet C; de Gramont A
Curr Treat Options Oncol; 2003 Oct; 4(5):405-11. PubMed ID: 12941200
[TBL] [Abstract][Full Text] [Related]
32. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
33. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.
Hind D; Tappenden P; Tumur I; Eggington S; Sutcliffe P; Ryan A
Health Technol Assess; 2008 May; 12(15):iii-ix, xi-162. PubMed ID: 18462574
[TBL] [Abstract][Full Text] [Related]
34. Evolving role of antineoplastic agents in colorectal cancer.
Adams VR
Am J Health Syst Pharm; 2006 May; 63(9 Suppl 2):S4-11. PubMed ID: 16641256
[TBL] [Abstract][Full Text] [Related]
35. Recent experience with oxaliplatin or irinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer.
Kuebler JP; de Gramont A
Semin Oncol; 2003 Aug; 30(4 Suppl 15):40-6. PubMed ID: 14523794
[TBL] [Abstract][Full Text] [Related]
36. Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.
Venook AP
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S74-84. PubMed ID: 19780248
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic advances in the management of metastatic colorectal cancer.
Freyer G; Ligneau B; Kraft D; Descos L; Trillet-Lenoir V
Expert Rev Anticancer Ther; 2001 Aug; 1(2):236-46. PubMed ID: 12113029
[TBL] [Abstract][Full Text] [Related]
38. Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer.
Jensen NF; Smith DH; Nygård SB; Rømer MU; Nielsen KV; Brünner N
Scand J Gastroenterol; 2012 Mar; 47(3):340-55. PubMed ID: 22181013
[TBL] [Abstract][Full Text] [Related]
39. Cetuximab for treatment of metastatic colorectal cancer.
Cerea G; Ricotta R; Schiavetto I; Maugeri MR; Sartore-Bianchi A; Moroni M; Artale S; Siena S
Ann Oncol; 2006 Jun; 17 Suppl 7():vii66-7. PubMed ID: 16760297
[TBL] [Abstract][Full Text] [Related]
40. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer.
Wong SF
Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
